• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kailera Therapeutics, Inc. - Common stock (NQ:KLRA)

20.83 +0.17 (+0.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,448,117
Open 20.27
Bid (Size) 18.00 (100)
Ask (Size) 24.00 (100)
Prev. Close 20.66
Today's Range 19.52 - 21.09
52wk Range 18.50 - 28.23
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Under-the-Radar Stocks to Buy and Hold for a Decade ↗
June 16, 2026
All three could become highly prominent biotech companies within 10 years. 
Via The Motley Fool
News headline image
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock? ↗
June 12, 2026
It's important to consider your comfort with risk before diving in. 
Via The Motley Fool
Topics Initial Public Offering

Performance

YTD
-19.9%
-19.9%
1 Month
-9.2%
-9.2%
3 Month
-19.9%
-19.9%
6 Month
-19.9%
-19.9%
1 Year
-19.9%
-19.9%

More News

Read More
News headline image
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026
From Kailera Therapeutics, Inc.
Via GlobeNewswire
News headline image
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
May 26, 2026
From Kailera Therapeutics, Inc.
Via GlobeNewswire
News headline image
Is Kailera Therapeutics a Buy After Its Sizzling IPO? ↗
May 16, 2026
Via The Motley Fool
Topics Initial Public Offering
News headline image
A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million ↗
April 27, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 20, 2026
From Kailera Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Kailera Therapeutics, Inc. - Common stock publicly traded?
Yes, Kailera Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Kailera Therapeutics, Inc. - Common stock trade on?
Kailera Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Kailera Therapeutics, Inc. - Common stock?
The ticker symbol for Kailera Therapeutics, Inc. - Common stock is KLRA on the Nasdaq Stock Market
What is the current price of Kailera Therapeutics, Inc. - Common stock?
The current price of Kailera Therapeutics, Inc. - Common stock is 20.83
When was Kailera Therapeutics, Inc. - Common stock last traded?
The last trade of Kailera Therapeutics, Inc. - Common stock was at 06/26/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap